Profile: American Life Science Pharmaceuticals focuses on developing new small molecule drugs for treating Alzheimer's disease. We specialize in the identification of key enzymes in the brain, called neuroproteases, which produce biologically active peptides that are thought to cause the disease. Our drug discovery process is designed to streamline and expedite the drug development process.